Bausch & Lomb: Is a Bidding War in Sight?

Some analysts believe Warburg Pincus may try to top Advanced Medical Optics' sweetened offer for the eye-care concern

Bausch & Lomb (BOL) was in focus again July 6 after it received a competing bid from a rival eye-care company that beats a prior all-cash offer from Warburg Pincus by $10 a share.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.